ChapterPDF Available

Creatine in Skeletal Muscle Physiology

Authors:

Figures

Content may be subject to copyright.
59
Nonvitamin and Nonmineral Nutritional Supplements. https://doi.org/10.1016/B978-0-12-812491-8.00008-4
© 2019 Elsevier Inc. All rights reserved.
Creatine in Skeletal Muscle Physiology
Massimo Negro*, Ilaria Avanzato* and Giuseppe D’Antona*,**
*CRIAMS-Sport Medicine Centre Voghera, University of Pavia, Pavia, Italy, **Department of Public Health, Experimental and Forensic Medicine,
University of Pavia, Pavia, Italy
INTRODUCTION
In 1992 Roger Harris and his colleagues discovered that exogenous creatine (Cr) administration enhances muscle Cr and
phosphocreatine (PCr) content (Harris etal., 1992). Since then Cr has become the most popular dietary supplement in
the field of sport and exercise physiology. In particular, Cr was used for the first time in the Olympic Games in Barcelona
by successful sprinters and, subsequently, has been used to enhance the physical performance in healthy individuals and
athletes. At present, a huge body of evidence, from more than 25years of research in the field, corroborates the efficacy
of Cr supplementation to promote physiological function in many types of exercise of varying duration and intensity,
and to aid improvements in strength, skeletal muscle mass, and bone mineral density, in healthy individuals and those
with neuromuscular diseases (Bazzucchi etal., 2009; Bemben etal., 2010; Bosco etal., 1997; Candow etal., 2015;
Chilibeck etal., 2015; D’Antona etal., 2014; Devries and Phillips, 2014; Griffen etal., 2015; Grindstaff etal., 1997;
Gualano etal., 2011, 2014; Hespel etal., 2001; Martone etal., 2015; Metzl etal., 2001; Mihic etal., 2000; Pearlman and
Fielding, 2006; Phillips, 2015; Ramirez-Campillo etal., 2015; Volek etal., 2004; Wilkinson etal., 2016). Indeed, Cr has
also been recently recognized as playing a role as an antioxidant, antinflammatory, and immunomodulatory compound
(Riesberg etal., 2016), as well as having interesting physiological effects on thermoregulation and cognitive performance
(Twycross-Lewis etal., 2016). In this chapter we will focus on the effects of Cr supplementation in skeletal muscle
physiology with particular attention to the known effects in healthy athletes.
CREATINE BACKGROUND
The Biochemistry of Creatine
Creatine (N-aminoiminomethyl-N-methylglycine, Cr) is a guanidine compound, which is endogenously synthesized by the
kidneys, pancreas, and liver, through a process that involves three amino acids as group donors: (1) a methyl group from
methionine, (2) an acetic group and nitrogen atom from glycine, and (3) an amide group from arginine (Fig.2.7.1). After
its production, Cr is mainly stored by the cardiac and skeletal muscle and brain. To perform its physiological role, Cr is
transformed into PCr by Cr kinase. The phosphate group is provided by adenosine triphosphate (ATP), which is converted
into adenosine diphosphate (ADP). PCr is a high-energy reserve, available for the conversion of ADP to ATP. This process
is essential during very intensive physical activity and relative high-energy request. Cr kinase catalyzes the reversible
transfer of the N-phosphoryl group from phosphoryl Cr to ADP to regenerate ATP and restore Cr skeletal muscle content
(Wyss etal., 2000).
The distribution of Cr kinase isoforms at a subcellular level has led to differing points of view regarding the function
of the Cr system. Wallimann etal. (1992) gave a description of the role of the different isoforms of Cr kinase. Cr kinase
isoforms are typically found in the cell cytoplasm and, in particular, at sites with a great ATP demand, e.g., plasma
membranes, sarcoplasmic reticulum, and myofibrils (Wallimann et al., 1992). A mitochondrial Cr kinase is also found
across mitochondrial membranes and, in the presence of Cr, it guarantees the conversion to PCr when the ATP obtained
from oxidative phosphorylation is available. These and other observations have promoted the fundamental role of Cr and
PCr in an energy shuttle system (ESS) of high-energy phosphates between the mitochondrial sites of ATP production
and the cytosolic sites of ATP utilization (Wallimann etal., 1992). The degree of involvement of this ESS depends on
Chapter 2.7
60 PART | II Nonessential Nutrients
different physiological muscle fiber requirements. Thus, in fast-twitch muscle fibers, mainly anaerobic/glycolytic, the ATP
production based on the efficacy of the ESS function predominates, whereas in slow-twitch, oxidative, the ESS function is
less important. The Cr/PCr system has a number of additional functions (Wallimann etal., 1992). These include maintaining
the cellular ATP/ADP ratio and buffering the products of ATP hydrolysis, which protects the thermodynamic efficiency of
ATP splitting. ATP hydrolysis generates ADP, phosphate, and a hydrogen ion. When high-intensity exercise occurs, the ATP
must be hydrolyzed very rapidly and it is essential that both ADP and the hydrogen ion are buffered so that: (1) prevention
of a rise in [ADP] caused by the Cr/PCr system reduces the inhibition of ATPases; (2) local cellular hydrogen production,
due to high rates of ATP utilization, is buffered by the Cr/PCr system when the Cr kinase reaction leads to ATP resynthesis
(Brosnan and Brosnan, 2007). Fig.2.7.2 illustrates the aspects of the Cr kinase system described above.
The Metabolism of Creatine: Loss, Replacement, and Tissue Transport Regulation
Cr and PCr elimination is primarily based on their break down to creatinine and its excretion through the urine. The rate of
Cr loss in humans is about 1.7% of the total body pool per day (Wyss etal., 2000), considering that in a 70-kg man the total
body Cr content is about 120 g, with a turnover of about 2 g/day (D’Antona etal., 2014). Since more than 90% of Cr and
PCr is found in skeletal muscle, Cr losses (and creatinine excretion) vary in relation to gender and age. Creatinine excretion
changes during life in an almost linear manner, reaching a maximum in 18–29year olds, with mean rates of loss of about
24 mg/kg per 24 h, reducing to mean rates of about 13 mg/kg per 24 h in 70–79year olds. Women have mean rates about
20% lower than men (Cockcroft and Gault, 1976).
Generally food provides 50% of our Cr daily requirement (approximately 1 g/day), with the body synthesizing the other
50% endogenously. Exogenous dietary sources of Cr include meat and fish, with Cr concentrations ranging from 4 to 5
g/kg in meat and from 4 to 10 g/kg in fish (D’Antona etal., 2014). No dietary Cr is available for vegans, and vegetarians
have very few sources of Cr in foods. Both vegans and vegetarians essentially require de novo synthesis for all of their
Cr stores, but studies have shown that Cr synthesis is insufficient in these subjects, with a decrease of serum/muscle Cr
levels compared to omnivores (Delanghe etal., 1989; Lukaszuk etal., 2002). Cr synthesis rates change during ageing and
Arginine:Glycine amidinotransferase
Arginine + Glycine ® Ornithine + GAA
Guanidinoacetate methyltransferase
AdoMet + GAA ® Creatine + AdoHcy
H2N
H2N
H2N
NH
H
2NH2N
H3C
CH3
NH2
OH OH
OH OH
O
S
O
N
N
N
N
NH2
O
S
OH OH
O
NN
NN
+
NH3
+
NH2
+
NH2
+
NH3
+
O
O
H
O
O
+
++
+H2N
NH3
+
NH
NH
O
O
H
O
O
O
O
H2N
NH2
+
NH
O
O
+
+H3N
FIG.2.7.1 Pathway of creatine synthesis. GAA, Guanidinoacetate; AdoMet, S-adenosyl-l-methionine; AdoHcy, S-adenosyl-l-homocysteine. (From
Brosnan, J.T., Brosnan, M.E., 2007. Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement. Annu. Rev. Nutr. 27, 241-261).
Creatine in Skeletal Muscle Physiology Chapter | 2.7 61
in individuals with a typical Western diet, aged between 20–39, 40–59, and over 60, the estimated rates of Cr synthesis
is about 7.7, 5.6, and 3.7 mmol/day, respectively. Women have mean rates of Cr synthesis of about 70%–80% of those
observed in men (Brosnan and Brosnan, 2007).
Typically, the tissues containing the most Cr (e.g., skeletal and cardiac muscle) are essentially unable to synthesize it.
A Cr transporter (CRT) mediates the uptake of Cr into different tissues such as the kidneys, cardiac muscle, brain, and
primarily skeletal muscle. Cr uptake into tissues occurs against a high concentration gradient: blood Cr concentrations
range from 50 to 100 μM while, for example, skeletal muscle Cr concentrations generally range from 5 to 10 mM. CRT is
a Na+-dependent neurotransmitter transporter (Gregor etal., 1995), enhanced by insulin. CRT activates Na+/K+-ATPase
and presumably increases the driving force for Cr uptake (Snow and Murphy, 2001). Cr transport may be regulated through
acute and chronic mechanisms. Acute regulation may be brought about by changes in the Cr concentration. Chronically, Cr
transport may be regulated by gene expression, translation, or posttranslational modification of the CRT. Furthermore, an
inverse relationship regulates Cr uptake and its intracellular concentration (Dodd etal., 1999). In fact, a high extracellular
Cr concentration initially causes an increase in transport, which is followed by a down-regulation of CRT expression and a
reduction in Cr transport (Loike etal., 1988).
CREATINE SUPPLEMENTATION: PROTOCOLS, PHARMACEUTICAL FORMS, AND THEIR
SAFETY
The most popular Cr intake protocol found in the literature includes a loading phase of 20 g/day for 5days (divided in four
daily doses), followed by a 2–5 g/day maintenance dose. Generally, skeletal muscle significantly increases its Cr content
over the first 2–3days of supplementation. During this time, the osmotic effects of Cr uptake are assumed to be responsible
for body water retention, leading to a reduction in urine output typically being observed (Ziegenfuss etal., 1998). Cr has
frequently been taken together with carbohydrates and this combination seems to increase its uptake into the skeletal
muscle, probably due to the effect of insulin. Different carbohydrate dosages were used in several trials, but the most
effective dosage to significantly improve Cr uptake in muscle was 100 g per 5 g of supplemented Cr (Green etal., 1996).
Exercise is another potent stimulus for Cr uptake by skeletal muscle. This finding was demonstrated for the first time
by Harris etal. (1992), in a typical one-leg study. Cr supplementation has been found to increase total muscle Cr (Cr
plus PCr) by about 25% and when coupled with exercise, by an average of 37%, without affecting muscle ATP levels
(Harris etal., 1992). Considerable interindividual variation exists in the degree of muscle loading after supplementation.
FIG.2.7.2 The creatine kinase/phosphocreatine system. ADP, Adenosine diphosphate; AT P, adenosine triphosphate; CK, creatine kinase; Cr, creatine;
PCr, phosphocreatine; CRT, Cr transporter; mtCK, mitochondrial CK isoforms; ANT, adenine nucleotide translocator; OP, oxidative phosphorylation;
G, glycolytic enzymes; CK-g, glycolytic CK; CK-c, cytosolic CK; CK-a, ATPases CK (transporters, pumps, enzymes). (Modified from Brosnan, J.T.,
Brosnan, M.E., 2007. Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement. Annu. Rev. Nutr. 27, 241-261).
62 PART | II Nonessential Nutrients
Although the reason for this is far from understood, it is clear that presupplement muscle Cr concentration is critical
(Rawson etal., 2002). Indeed, an inverse relationship between the increase in muscle PCr following supplementation in the
young (between 20 and 32years of age) and their Cr presupplementation levels has been established (Fig.2.7.3).
Cr monohydrate (CM) is the form most frequently cited in scientific literature and most commonly found in dietary
supplement/food products (Jäger etal., 2011). Besides CM, other Cr forms (Table 2.7.1) were recently introduced into
the market, with claims that they exhibit a higher physical performance improvement, bioavailability, effectiveness, and/
or safety profile than CM (Andres etal., 2016). However, to support these marketing claims there is little to no evidence
available in the literature (Jäger etal., 2011).
At present, there are no clinically significant side effects reported following CM supplementation at recommended
doses, unlike weight gain—an attribute often required by many athletes and subjects affected by muscle diseases (Bender
etal., 2008; Dalbo etal., 2008; Kreider etal., 2003a; Schilling etal., 2001).
CREATINE SUPPLEMENTATION AND PHYSICAL PERFORMANCE
Cr supplementation and its effects on strength and muscular performance have been widely studied. The International
Society of Sports Nutrition’s (ISSN) position claims Cr to be the most effective food supplement available so far for
increasing high-intensity exercise and gaining lean muscle mass (Kreider etal., 2010). Typical studies indicate that Cr
supplementation during training can increase one-repetition maximum (1RM) strength and power. Recently, a metaanalysis
of 63 studies showed that Cr supplementation enhances 1RM leg press and 1RM squat by 3% and 8%, respectively (Lahners
etal., 2015). In several experimental conditions the potential of Cr on anaerobic performance parameters such as total
working capacity, peak power output, resistance capacity, total work performed, total strength expressed, and others, have
been extensively demonstrated (Wilborn, 2015).
Strength, power, and muscle-building athletes are typically users of Cr supplements, although evidence suggests some
benefits for endurance athletes could also be obtained. In particular, Cr supplementation has not been linked to functional
improvement in runners involved in distance races longer than 5000 m, but performance increases could be obtained over
shorter and/or intermittent training for distances under 2000 m (Earnest, 1997; Earnest etal., 1997). The Cr supplementation
effectiveness on endurance capacity can be attributed to several mechanisms: (1) PCr aids ATP resynthesis, in a decreasing
role in relation to duration and intensity of muscle work (Bangsbo etal., 1990); (2) Cr may help produce ATP aerobically,
considering the ESS function of Cr between the mitochondria and muscle fibers (Wallimann etal., 1992); and (3) muscle Cr
can support anaerobic glycolysis and this may lead to a reduced intramuscular lactate production (Earnest and Rasmussen,
2015). Furthermore, based on the osmotic effects of Cr uptake (Ziegenfuss etal., 1998), the use of Cr in endurance sports
65%
60%
55%
50%
45%
40%
35%
30%
25%
20%
15%
16 17 18
r = 0.76; p = 0.03
Initial muscle PCr (mmol/kg)
Increase in muscle PCr (%)
19 20 21 22 23
24
FIG.2.7.3 The increase in muscle phosphocreatine (PCr) after creatine supplementation is inversely related to presupplementation PCr levels.
(From Brosnan, J.T., Brosnan, M.E., 2007. Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement. Annu. Rev. Nutr. 27, 241-261).
Creatine in Skeletal Muscle Physiology Chapter | 2.7 63
(alone or in combination with other compounds) has been speculated as a possible strategy for preserving hydration and
minimizing sweat loss (Beis etal., 2011; Easton etal., 2007; Francaux and Poortmans, 1999; Polyviou etal., 2012; Saab
etal., 2002; Watson etal., 2006). However, despite the fact that some effects of Cr supplementation on thermoregulatory
and cardiovascular responses have been reported, this does not seem to affect significantly muscle work capacity in hot
environments (Beis etal., 2011; Easton etal., 2007; Kilduff etal., 2004; Polyviou etal., 2012). Other studies have failed to
observe any effects of Cr on thermoregulation (Bennett etal., 2001; Branch etal., 2007; Oopik etal., 1998; Rosene etal.,
2015; Terjung etal., 2000).
Creatine Supplementation and Muscle Hypertrophy
In several strength and power/speed sports an increase in muscle mass is often required to improve performance by
athletes. Based on this statement, the hypertrophic effects of Cr supplementation have been investigated in different papers.
During a typical Cr loading period (first 5–7days), data indicate that individuals will experience approximately 0.6–2.0
kg gains in lean body mass (Earnest etal., 1995; Green etal., 1996; Kreider etal., 1998; Kreider, 2003). Furthermore, Cr
supplementation during chronic resistance exercise studies (approximately 6–8weeks) has shown to increase the lean body
mass by about 3 kg (Earnest etal., 1995; Kreider etal., 1996; Stout etal., 1999). Other studies indicate that 4–8weeks
of strength training coupled with Cr supplementation, in combination with other substances (e.g., glucose), can stimulate
greater gains in lean mass when compared to Cr supplementation alone (Kreider etal., 1998; Stout et al., 1997). These
results are typically observed in men, but similar gains in lean muscle mass have been also reported in women.
Initial studies investigating the role of Cr supplementation suggested that additional water retention in the muscle
primar ily contributes to the gain in mass. However, subsequent research suggested that Cr supplementation increases body mass
through greater muscle protein synthesis and therefore of muscle fiber hypertrophy. From this point of view the pioneering
TABLE2.7.1 Different Forms of Creatine and Their Creatine Content Percentage (Jäger etal., 2011)
Form of creatine Creatine content (%) Difference in CM (%)
Creatine anhydrous 100.0 +13.8
CM 87.9 0
Creatine ethyl ester 82.4 –6.3
Creatine malate (3:1) 74.7 –15.0
Creatine methyl ester HC1 72.2 –17.9
Creatine citrate (3:1) 66 –24.9
Creatine malate (2:1) 66 –24.9
Creatine pyruvate 60 –31.7
Creatine a-amino butyrate 56.2 –36.0
Creatine a-ketoglutarate 53.8 –38.8
Sodium creatine phosphate 51.4 –41.5
Creatine taurinate 51.4 –41.6
Creatine pyroglutamate 50.6 –42.4
Creatine ketoisocaproate 50.4 –42.7
Creatine orotate (3:1) 45.8 –47.9
Carnitine creatinate 44.9 –49.0
Creatine decanoate 43.4 –50.7
Creatine gluconate 40.2 –54.3
CM, Creatine monohydrate.
64 PART | II Nonessential Nutrients
contribution made by Volek etal. (1999) is very interesting, demonstrating that a Cr ingestion in resistance-trained males
increased significantly the muscle fiber cross-sectional area in each of the muscle fiber types observed: type I (35% vs.
11%), type IIA (36% vs. 15%), and type IIX (35% vs. 6%). Based on these findings, Willoughby and Rosene further
examined the effects of Cr supplementation on gene and myosin heavy-chain protein expression of contractile filaments
(Willoughby and Rosene, 2001, 2003). The conclusion by the authors indicated that increases in lean body mass are not
solely attributable to greater water retention in the muscle, but rather to regulation of protein synthesis through a different
gene expression of myogenic regulatory factors induced by Cr. These myogenic regulatory factors (e.g., MRF-4, Myf-5,
Myo-D, and myogenin) act to control gene expression by binding to DNA and subsequently promoting muscle-specific
gene transcription of fundamental muscular proteins such as myosin heavy chain, myosin light chain, α-actinin, troponin I,
and Cr kinase (Lowe etal., 1998). Furthermore, the influence of Cr supplementation on satellite cell (SC) function, based
on myonuclear domain theory, was explored by Olsen etal. (2006) and Safdar etal. (2008).
Olsen etal. (2006) demonstrated that Cr ingestion (load: 24 g/day, 6 g/serving, 4 servings/day, 7days; maintenance:
6 g/day, 1 serving/day, 15weeks) during a resistance exercise promotes the proliferation of SCs and stimulates the
myonuclei relative distribution in skeletal muscle. Safdar etal. (2008) referred that supplementation of Cr (load: 20 g/day,
10 g/ serving, 2 servings/day, 3days; maintenance: 5 g/day, 1 serving/day, 7days) induces proliferation and differentiation
of SCs thus activating genes of cytoskeletal remodeling.
Creatine Supplementation and Exercise-Induced Muscle Damage and Injuries
High-intensity muscle work leads to myofibrillar damage in athletes. Muscle recovery passes through structural reparation
and Cr supplementation has been demonstrated to regulate at least four important mechanisms involved in the regeneration
process (Kim J etal., 2015).
(1) The first mechanism concerns the inflammatory response induced by exercise-induced muscle damage. Santos etal.
(2004) showed that 20 g/day of Cr, administrated to 34 male runners for 5days before a competition, diminished
prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), and lactate dehydrogenase (LDH) after a competition of
30 km. In agreement with these data, Bassit etal. (2008) described how 11 male triathletes who introduced 20 g/day
of Cr for 5days before a half-Ironman contest had reductions in postexercise levels of interferon-α (INF-α), TNF-α,
PGE2, and interleukin-1β (IL-1β). Deminice etal. (2013) referred that 0.3 g/kg of Cr ingested for 7days suppresses
the rise in TNF-α after a repeated bout of anaerobic running tests.
(2) The second possible Cr mechanism is to reduce oxidative stress (Lawler etal., 2002; Rahimi, 2011). One of the first
pieces of evidence for the antioxidant capacity of Cr was described by Lawler etal. (2002). Later a subsequent study
(Deminice and Jordao, 2012) indicated that Cr ingestion during the 28days before acute muscle activity diminishes
lipid hydroperoxides and thiobarbituric acid-reactive substances (TBARS) with an increase of total antioxidant
capacity and in particular glutathione (GSH) and glutathione disulfide (GSSG) ratio. In another clinical trial, for 7days
Rahimi (2011) administrated 20 g/day of Cr to individuals who went on to show decreased levels of 8-hydroxy-2-
deoxyguanosine (8-OHdG) and malonyldialdehyde (MDA) in the blood after a resistance exercise session. Contrary
to this, other studies reported that Cr supplementation does not decrease oxidative stress after exercise-induced muscle
damage (Deminice etal., 2013; Silva etal., 2013). Although the role of Cr on exercise-related oxidative stress is very
interesting, poor data are available at present and this mechanism needs to be investigated in more detail.
(3) The third mechanism of action of Cr possibly involves the regulation of muscle calcium trafficking. Muscle damage
may increase calcium concentrations in the cytosol due to an impaired sarcoplasmic reticulum function, leading to
further muscle damage (Beaton et al., 2002). Cr regulates the sarcoplasmic reticulum calcium pump function by
phosphorylating ADP to ATP and decreasing cytosolic calcium levels (Cooke etal., 2009; Korge etal., 1993). From
this point of view, Minajeva etal. (1996) proposed that an increase of muscle PCr, with Cr supplementation, promotes
ATP regeneration leading to an attenuation of calcium-related damage. However, this hypothesis needs investigation.
(4) The last mechanism has been associated with SC activation and proliferation (Olsen etal., 2006; Safdar etal., 2008).
SCs are known to play a key role during the regeneration process after muscle damage (Paulsen etal., 2012) and the
role of Cr supplementation has already been shown in the previous paragraph.
CONCLUSION AND FUTURE DIRECTION
At present, there is an important core reference that underlines how Cr supplementation is safe and can lead to significant
performance enhancement. The positive effect of Cr on muscle physiology is useful in several anaerobic/aerobic
Creatine in Skeletal Muscle Physiology Chapter | 2.7 65
exercise, resistance, and speed training programs, as well as intermittent exercise and muscle hypertrophy programs. Cr
supplementation may also prevent exercise-induced muscle damage, facilitating recovery after training sessions and/or
contests, and this can facilitate muscle sports-specific adaptation. However, a clear comprehension of how Cr can regulate
the complex muscle subcellular signal network during exercise recovery needs to be better established with other well-
designed studies. In addition, Cr promises to be effective on bone metabolism but available data on its effect on bone
accretion are still inconsistent (and beyond the topic of the chapter). In conclusion, further accurate study must be designed
with appropriate groups of subjects and longer duration treatments (>52weeks) to understand the unclear mechanisms by
which Cr supplementation can, in the long term, affect the physiology of the muscle.
REFERENCES
Andres, S., Ziegenhagen, R., Trefflich, I., Pevny, S., Schultrich, K., Braun, H., Schänzer, W., Hirsch-Ernst, K.I., Schäfer, B., Lampen, A., 2016. Creatine
and creatine forms intended for sports nutrition. Mol. Nutr. Food Res. https://doi.org/10.1002/mnfr.201600772.
Bangsbo, J., Gollnick, P.D., Graham, T.E., Juel, C., Kiens, B., Mizuno, M., Saltin, B., 1990. Anaerobic energy production and O2 deficit–debt relationship
during exhaustive exercise in humans. J. Physiol. 422, 539–559.
Bassit, R.A., Curi, R., Costa Rosa, L.F., 2008. Creatine supplementation reduces plasma levels of pro-inflammatory cytokines and PGE2 after a half-
ironman competition. Amino Acids 35, 425–431.
Bassit, R.A., Pinheiro, C.H., Vitzel, K.F., Sproesser, A.J., Silveira, L.R., Curi, R., 2010. Effect of short-term creatine supplementation on markers of
skeletal muscle damage after strenuous contractile activity. Eur. J. Appl. Physiol. 108, 945–955.
Bazzucchi, I., Felici, F., Sacchetti, M., 2009. Effect of short-term creatine supplementation on neuromuscular function. Med. Sci. Sports Exerc. 41,
1934–1941.
Beaton, L.J., Tarnopolsky, M.A., Phillips, S.M., 2002. Contraction-induced muscle damage in humans following calcium channel blocker administration.
J. Physiol. 544, 849–859.
Beis, L.Y., Polyviou, T., Malkova, D., Pitsiladis, Y.P., 2011. The effects of creatine and glycerol hyperhydration on running economy in well trained
endurance runners. JISSN 8, 24.
Bemben, M.G., Willem, M.S., Carter, J.M., Eliot, K.A., Knehans, A.W., Bemben, D.A., 2010. The effects of supplementation with creatine and protein on
muscle strength following a traditional resistance training programme. J. Nutr. Health Aging 14, 155–159.
Bender, A., Samtleben, W., Elstner, M., Klopstock, T., 2008. Long-term creatine supplementation is safe in aged patients with Parkinson disease. Nutr.
Res. 28 (3), 172–178.
Bennett, T., Bathalon, G., Armstrong, D.JIII, Martin, B., Cool, R., Beck, R., Barkdull, T., O’Brien, K., Deuster, P.A., 2001. Effects of creatine on
performance of militarily relevant tasks and solider health. Mil. Med. 166, 996–1002.
Bosco, C., Tihanyi, J., Puscpk, J., Kovacs, I., Gabossy, A., Colli, R., Pulvirenti, G., Tranquilli, C., Foti, C., Viru, M., Viru, A., 1997. Effects of oral creatine
supplementation on jumping and running performance. Int. J. Sports Med. 18, 369–372.
Branch, J.D., Schwarz, W.D., Van Lunen, B., 2007. Effect of creatine supplementation on cycle ergometer exercise in a hyperthermic environment. J.
Strength Cond. Res. 21, 57–61.
Brosnan, J.T., Brosnan, M.E., 2007. Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu. Rev. Nutr. 27, 241–261.
Candow, D.G., Vogt, E., Johannsmeyer, S., Forbes, S.C., Farthing, S.C., Farthing, J.P., 2015. Strategic creatine supplementation and resistance training in
healthy older adults. Appl. Physiol. Nutr. Metab. 40, 689–694.
Chilibeck, P.D., Candow, D.G., Landeryou, T., Kaviani, M., Paus-Jessen, L., 2015. Effects of creatine and resistance training on bone health in
postmenopausal woman. Med. Sci. Sports Exerc. 47, 1587–1595.
Cockcroft, D.W., Gault, M.H., 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16, 31–41.
Cooke, M.B., Rybalka, E., Williams, A.D., Cribb, P.J., Hayes, A., 2009. Creatine supplementation enhances muscle force recovery after eccentrically-
induced muscle damage in healthy individuals. J. Int. Soc. Sports Nutr. 6, 13.
D’Antona, G., Nabavi, S.M., Micheletti, P., Di Lorenzo, A., Aquilani, R., Nisoli, R., Rondanelli, M., Daglia, M., 2014. Creatine, L-carnitine, and ω3
polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle. Biomed. Res. Int. 2014, 613890.
Dalbo, V.J., Roberts, M.D., Stout, J.R., Kerksick, C.M., 2008. Putting to rest the myth of creatine supplementation leading to muscle cramps and
dehydration. Br. J. Sports Med. 42 (7), 567–573.
Delanghe, J., De Slypere, J.P., De Buyzere, M., Robbrecht, J., Wieme, R., Vermeulen, A., 1989. Normal reference values for creatine, creatinine and
carnitine are lower in vegetarians. Clin. Chem. 35, 1802–1803.
Deminice, R., Jordao, A.A., 2012. Creatine supplementation reduces oxidative stress biomarkers after acute exercise in rats. Amino Acids 43, 709–715.
Deminice, R., Rosa, F.T., Franco, G.S., Jordao, A.A., de Freitas, E.C., 2013. Effects of creatine supplementation on oxidative stress and inflammatory
markers after repeated-sprint exercise in humans. Nutrition 29, 1127–1132.
Devries, M.C., Phillips, S.M., 2014. Creatine supplementation during resistance training in older adults—a meta-analysis. Med. Sci. Sports Exerc. 46,
1193–1203.
Dodd, J.R., Zheng, T., Christie, D.L., 1999. Creatine accumulation and exchange by HEK293 cells stably expressing high levels of a creatine transporter.
Biochim. Biophys. Acta 1472, 128–136.
Earnest, C.P., 1997. Effect of acute creatine monohydrate ingestion on anaerobic capacity. Kinesiology 141, .
66 PART | II Nonessential Nutrients
Earnest, C.P., Almada, A.L., Mitchell, T.L., 1997. Effect of creatine monohydrate ingestion on intermediate length anaerobic treadmill running to
exhaustion. J. Strength Cond. Res. 4, 234–238.
Earnest, C.P., Snell, P., Rodriguez, R., Almada, A., Mitchell, T., 1995. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular
strength and body composition. Acta Physiol. Scand. 153 (2), 207.
Earnest, C.P., Rasmussen, C., 2015. Nutritional supplements for endurance athletes. In: Greenwood, M., Cooke, M.B., Ziegenfuss, T., Kalman, D.S.,
Antonio, J. (Eds.), Nutritional Supplements in Sports and Exercise. Springer International Publishing, Switzerland, pp. 253–272.
Easton, C., Turner, S., Pitsiladis, Y.P., 2007. Creatine and glycerol hyperhydration in trained subjects before exercise in the heat. Int. J. Sport Nutr. Exerc.
Metab. 17, 70–91.
Francaux, M., Poortmans, J.R., 1999. Effects of training and creatine supplementation on muscle strength and body mass. Eur. J. Appl. Physiol. Occup.
Physiol. 80, 165–168.
Green, A.L., Hultman, E., Macdonald, I.A., Sewell, D.A., Greenhaff, P.L., 1996. Carbohydrate ingestion augments skeletal muscle creatine accumulation
during creatine supplementation in humans. Am. J. Physiol. 271, E821–E826.
Gregor, P., Nash, S.R., Caron, M.G., Seldin, M.F., Warren, S.T., 1995. Assignment of the creatine transporter gene (SLC6A8) to human chromosome Xq28
telomeric to G6PD. Genomics 25, 332–333.
Griffen, C., Rogerson, D., Ranchordas, M., Ruddock, A., 2015. Effects of creatine and sodium bicarbonate coingestion on multiple indices of mechanical
power output during repeated wingate tests in trained men. Int. J. Sport Nutr. Exerc. Metabol. 25, 298–306.
Gualano, B., Salles, D.E., Painnelo, V., Artoli, G.G., Neves, M.JJr., De Sá Pinto, A.L., Da Silva, M.E., Cunha, M.R., Otaduy, M.C., da Leite, C.C., Ferreira,
J.C., Pereira, R.M., Brum, P.C., Bonfá, E., Lancha, A.H.JJr., 2011. Creatine in type 2 diabetes: a randomized, double-blind, placebo controlled trial.
Med. Sci. Sports Exerc. 43, 770–778.
Gualano, B., Macedo, A.R., Alves, C.R., Roschel, H., Benatti, F.B., Takayama, L., de Sá Pinto, A.L., Lima, F.R., Pereira, R.M., 2014. Creatine
supplementation and resistance training in vulnerable older woman: a randomised double-blind placebo-controlled clinical trial. Exp. Gerontol. 53,
7–15.
Grindstaff, P.D., Krieder, R., Bishop, R., Wilson, M., Wood, L., Alexander, C., Almada, A., 1997. Effects of oral creatine supplementation on repetitive
spring performance and body composition in competitive swimming. Int. J. Sports Nutr. 7, 330–346.
Harris, R.C., Soderlund, K., Hultman, E., 1992. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation.
Clin. Sci. (Lond.) 83, 367–374.
Hespel, P., Op’t, E.B., van Leemputte, M., Ursø, B., Greenhaff, P., Labargue, V., Dymarkowski, S., Van Hecke, P., Richter, E.A., 2001. Oral creatine
supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J. Physiol. 536,
625–633.
Jäger, M.P., Shao, A., Inoue, T., Kreider, R.B., 2011. Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids 40,
1369–1383.
Kilduff, L.P., Georgiades, E., James, N., Misnnion, R.H., Mitchell, M., Kingsmore, D., Hadjicharlambous, M., Pitsiladis, Y.P., 2004. The effects of creatine
supplementation on cardiovascular, metabolic, and thermoregulatory responses during exercise in the heat in endurance-trained humans. Int. J. Sports
Nutr. 14, 443–460.
Kim, J., Lee, J., Kim, S., Yoon, D., Kim, J., Sung, D.J., 2015. Role of creatine supplementation in exercise-induced muscle damage: a mini review. J.
Exerc. Rehabil. 11 (5), 244–250.
Korge, P., Byrd, S.K., Campbell, K.B., 1993. Functional coupling between sarcoplasmic-reticulum-bound creatine kinase and Ca(2+)-ATPase. Eur. J.
Biochem. 213, 973–980.
Kreider, R.B., 2003. Effects of creatine supplementation on performance and training adaptations. Mol. Cell. Biochem. 244 (1–2), 89–94.
Kreider, R.B., Ferreira, M., Wilson, M., Grindstaff, P., Plisk, S., Reinardy, J., Cantler, E., Almada, A.L., 1998. Effects of creatine supplementation on body
composition, strength, and sprint performance. Med. Sci. Sports Exerc. 30, 73–82.
Kreider, R.B., Melton, C., Rasmussen, C.J., Greenwood, M., Lancaster, S., Cantler, E.C., Milnor, P., Almada, A.L., 2003a. Long-term creatine
supplementation does not significantly affect clinical markers of health in athletes. Mol. Cell. Biochem. 244 (1–2), 95–104.
Kreider, R.B., Klesges, R., Harmon, K., Grindstaff, P., Ramsey, L., Bullen, D., Wood, L., Li, Y., Almada, A., 1996. Effects of ingesting supplements
designed to promote lean tissue accretion on body composition during resistance training. Int. J. Sport Nutr. 6, 234–246.
Kreider, R.B., Wilborn, C.D., Taylor, L., Campbell, B., Almada, A.L., Collins, R., Cooke, M., Earnest, C.P., Greenwood, M., Kalman, D.S., Kerksick,
C.M., Kliener, S.M., Leutholtz, B., Lopez, H., Lowery, L.M., Mendel, R., Smith, A., Spano, M., Wildman, R., Willougby, D.S., Zeigenfuss, T.N.,
Antonio, J., 2010. ISSN exercise & sport nutrition review: research & recommendations. JISSN 7, 7.
Lahners, C., Pereira, B., Naughton, G., Trousselard, M., Lesarge, F.X., Dutheil, F., 2015. Creatine supplementation on lower limb performance: a
systematic review and meta-analysis. Sports Med. 45, 1285–1294.
Lawler, J.M., Barnes, W.S., Wu, G., Song, W., Demaree, S., 2002. Direct antioxidant properties of creatine. Biochem. Biophys. Res. Commun. 290, 47–52.
Loike, J.D., Zalutsky, D.L., Kaback, E., Miranda, A.F., Silverstein, S.C., 1988. Extracellular creatine regulates creatine transport in rat and human muscle
cells. Proc. Natl. Acad. Sci. U.S.A. 85, 807–811.
Lowe, D.A., Lund, T., Always, S.E., 1998. Hypertrophy stimulated myogenic regulatory factor mRNA increases are attenuated in fast muscle of aged
quails. Am. J. Physiol. 275 (1), C155–C162.
Lukaszuk, J.M., Robertson, R.J., Arch, J.E., Moore, G.E., Yaw, K.M., Kelley, D.E., Rubin, J.T., Moyna, N.M., 2002. Effect of creatine supplementation
and a lacto-ovo-vegetarian diet on muscle creatine concentration. Int. J. Sports Exerc. Metab. 12, 336–348.
Martone, A.M., Lattanzio, F., Abbetecola, A.M., Carpia, D.L., Tosato, M., Marzetti, E., Calvani, R., Onder, G., Landi, F., 2015. Treating sarcopenia in
older and oldest old. Curr. Pharm. Des. 21, 1715–1722.
Creatine in Skeletal Muscle Physiology Chapter | 2.7 67
Metzl, J.D., Small, E., Levine, S.R., Gershel, J.C., 2001. Creatine use among young athletes. Pediatrics 108, 421–425.
Mihic, S., MacDonald, J.R., McKenzie, S., Tarnopolsky, M.A., 2000. Acute creatine loading increases fat-free mass, but does not affect blood pressure,
plasma creatinine, or CK activity in men and women. Med. Sci. Sports Exerc. 32, 291–296.
Minajeva, A., Ventura-Clapier, R., Veksler, V., 1996. Ca2+ uptake by cardiac sarcoplasmic reticulum ATPase in situ strongly depends on bound creatine
kinase. Pflugers Arch. 432, 904–912.
Olsen, S., Aagaard, P., Kadi, F., Tufekovic, G., Verney, J., Olesen, J.L., Suetta, C., Kjaer, M., 2006. Creatine supplementation augments the increase in
satellite cell and myonuclei number in human skeletal muscle induced by strength training. J. Physiol. 573, 525–534.
Oopik, V., Paasuke, P., Timpmann, S., Medijainen, L., Ereline, J., Smirova, T., 1998. Effect of creatine supplementation during rapid body mass reduction
on metabolism and isokinetic muscle performance capacity. Eur. J. Appl. Physiol. 78, 83–92.
Paulsen, G., Mikkelsen, U.R., Raastad, T., Peake, J.M., 2012. Leucocytes, cytokines and satellite cells: what role do they play in muscle damage and
regeneration following eccentric exercise? Exerc. Immunol. Rev. 18, 42–97.
Pearlman, J.P., Fielding, R.A., 2006. Creatine monohydrate as a therapeutic aid in muscular dystrophy. Nutr. Rev. 64, 80–88.
Phillips, S.M., 2015. Nutritional supplements in support of resistance exercise to counter age-related sarcopenia. Adv. Nutr. 15, 452–460.
Polyviou, T., Pitsiladis, Y.P., Lee, W.C., Pantazis, T., Hambly, C., Speakman, J.R., Malkova, D., 2012. Thermoregulatory and cardiovascular responses to
creatine, glycerol and alpha lipoic acid in trained cyclists. JISSN 9, 29.
Rahimi, R., 2011. Creatine supplementation decreases oxidative DNA damage and lipid peroxidation induced by a single bout of resistance exercise. J.
Strength Cond. Res. 25, 3448–3455.
Ramirez-Campillo, R., Gonzales-Jurado, J.A., Martinez, C., Nakamura, F.Y., Peñailillo, L., Meylan, C.M., Caniuqueo, A., Cañas-Jamet, R., Moran,
J., Alonso-Martinez, A.M., Izguierdo, M., 2015. Effects of plyometric training and creatine supplementation on maximal intensity exercise and
endurance in female soccer players. J. Sci. Med. Sport 6, S1440–S2440.
Rawson, E.S., Clarkson, P.M., Price, T.B., Miles, M.P., 2002. Differential response of muscle phosphocreatine to creatine supplementation in young and
old subjects. Acta Physiol. Scand. 174, 57–65.
Riesberg, L.A., Weed, S.A., Mc Donald, T.L., Eckerson, J.M., Drescher, K.M., 2016. Beyond muscles: the untapped potential of creatine. Int.
Immunopharmacol. 37, 31–42.
Rosene, J.M., Matthews, T.D., McBride, R.J., Galla, A., Hann, M., McDonald, K., Gague, N., Lea, J., Kasen, J., Farias, C., 2015. The effects of creatine
supplementation on thermoregulation and isokinetic muscular performance following acute (3-day) supplementation. J. Sports Med. Phys. Fitness
55, 1488–1496.
Saab, G., Marsh, G.D., Casselman, M.A., Thompson, R.T., 2002. Changes in human muscle transverse relaxation following short-term creatine
supplementation. Exp. Physiol. 87, 383–389.
Safdar, A., Yardley, N.J., Snow, R., Melov, S., Tarnopolsky, M.A., 2008. Global and targeted gene expression and protein content in skeletal muscle of
young men following short-term creatine monohydrate supplementation. Physiol. Genomics 32, 219–228.
Santos, R.V., Bassit, R.A., Caperuto, E.C., Costa Rosa, L.F., 2004. The effect of creatine supplementation upon inflammatory and muscle soreness
markers after a 30 km race. Life Sci. 75, 1917–1924.
Schilling, B.K., Stone, M.H., Utter, A., Kearney, J.T., Johnson, M., Coglianese, R., Smith, L., O’Bryant, H.S., Fry, A.C., Starks, M., Keith, R., Stone, M.E.,
2001. Creatine supplementation and health variables: a retrospective study. Med. Sci. Sports Exerc. 33 (2), 183–188.
Silva, L.A., Tromm, C.B., Da Rosa, G., Bom, K., Luciano, T.F., Tuon, T., De Souza, C.T., Pinho, R.A., 2013. Creatine supplementation does not decrease
oxidative stress and inflammation in skeletal muscle after eccentric exercise. J. Sports Sci. 31, 1164–1176.
Snow, R.J., Murphy, R.M., 2001. Creatine and the creatine transporter: a review. Mol. Cell. Biochem. 224, 169–181.
Stout, J., Eckerson, J., Noonan, D., Moore, G., Cullen, D., 1997. The effects of a supplement designed to augment creatine uptake on exercise performance
and fat-free mass in football players 1429. Med. Sci. Sports Exerc. 295 (251).
Stout, J., Eckerson, J., Noonan, D., Moore, G., Cullen, D., 1999. Effects of 8weeks of creatine supplementation on exercise performance and fat-free
weight in football players during training. Nutr. Res. 19 (2), 217–225.
Terjung, R.L., Clarkson, P., Eichner, E.R., Greenhaff, P.L., Hespel, P.J., Israel, R.G., Kraemer, W.J., Meyer, R.A., Spriet, L.L., Tarnopolsky, M.A.,
Wagenmakers, A.J.M., Williams, M.H., 2000. American College of Sports Medicine roundtable. The physiological and health effects of oral creatine
supplementation. Med. Sci. Sports Exerc. 32, 706–717.
Twycross, L.R., Kilduff, L.P., Wang, G., Pitsiladis, Y.P., 2016. The effects of creatine supplementation on thermoregulation and physical (cognitive)
performance: a review and future prospects. Amino Acids 48 (8), 1843–1855.
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., Eppenberger, H.M., 1992. Intracellular compartmentation, structure and function of creatine kinase
isoenzymes in tissues with high and fluctuating energy demands: the “phosphocreatine circuit” for cellular energy homeostasis. Biochem. J. 281,
21–40.
Watson, G., Casa, D.J., Fiala, K.A., Hile, A., Roti, M.W., Healey, J.C., Armstrong, L.E., Maresh, C.M., 2006. Creatine use and exercise heat tolerance in
dehydrated men. J. Athl. Train. 41, 18–29.
Wilborn, C., 2015. Nutritional supplements for strength and power athletes. In: Greenwood, M. (Ed.), Nutritional Supplements in Sports and Exercise.
Springer International Publishing, Switzerland, pp. 224–227.
Wilkinson, T.J., Lemmey, A.B., Jones, J.G., Sheikh, F., Ahmed, Y.A., Chitale, S., Maddison, P.J., O’Brien, T.D., 2016. Can creatine supplementation
improve body composition and objective physical function in rheumatoid arthritis patients? A randomised controlled trial. Arthritis Care Res. 68 (6),
729–737.
Willoughby, D.S., Rosene, J.M., 2001. Effects of oral creatine and resistance training on myosin heavy chain expression. Med. Sci. Sports Exerc. 33 (10),
1674–1681.
68 PART | II Nonessential Nutrients
Willoughby, D.S., Rosene, J.M., 2003. Effects of oral creatine and resistance training on myogenic regulatory factor expression. Med. Sci. Sports Exerc.
35 (6), 923–929.
Volek, J.S., Duncan, N.D., Mazzetti, S.A., Staron, R.S., Putukian, M., Gomez, A., Pearson, D.R., Fink, W.J., Kraemer, W.J., 1999. Performance and
muscle fiber adaptations to creatine supplementation and heavy resistance training. Med. Sci. Sports Exerc. 31, 1147–1156.
Volek, J.S., Ratamess, N.A., Rubin, M.R., Gómez, A.L., French, D.N., McGuigan, M.M., Scheett, T.P., Sharman, M.J., Häkkinen, K., Kraemer, W.J., 2004.
The effect of creatine supplementation on muscular performance and body composition responses to short-term resistance training overreaching. Eur.
J. Appl. Physiol. 91, 628–637.
Ziegenfuss, T.N., Lowery, L.M., Lemon, P.W.R., 1998. Acute fluid and volume changes in men during three days of creatine supplementation. J. Exerc.
Physiol. 1, 1–10.
FURTHER READING
Crassous, B., Richard-Bulteau, H., Deldicque, L., Serrurier, B., Pasdeloup, M., Francaux, M., Bigard, X., Koulmann, N., 2009. Lack of effects of creatine
on the regeneration of soleus muscle after injury in rats. Med. Sci. Sports Exerc. 41, 1761–1769.
Kanda, K., Sugama, K., Hayashida, H., Sakuma, J., Kawakami, Y., Miura, S., Yoshioka, H., Mori, Y., Suzuki, K., 2013. Eccentric exercise-induced
delayed-onset muscle soreness and changes in markers of muscle damage and inflammation. Exerc. Immunol. Rev. 19, 72–85.
Tidball, J.G., 2005. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, 345–353.
Wyss, M., Kaddurah-Daouk, R., 2000. Creatine and creatinine metabolism. Physiol. Rev. 80 (3), 1107–1213.
... Thus, Cr -an amino acid derivative component -has become the most popular dietary supplement in exercise physiology and sport. First taken in the Olympic Games in Barcelona by successful sprinters, Cr has been used afterwards to increase the physical performance in athletes and in healthy individuals (3). At present, a huge body of evidence supports the efficacy of Cr supplementation to enhance physiological function in many types of exercise of different duration and intensity, and to improve skeletal muscle mass, strength, and even bone mineral density in healthy individuals or in those with neuromuscular diseases (3)(4)(5)(6)(7)(8)(9). ...
... First taken in the Olympic Games in Barcelona by successful sprinters, Cr has been used afterwards to increase the physical performance in athletes and in healthy individuals (3). At present, a huge body of evidence supports the efficacy of Cr supplementation to enhance physiological function in many types of exercise of different duration and intensity, and to improve skeletal muscle mass, strength, and even bone mineral density in healthy individuals or in those with neuromuscular diseases (3)(4)(5)(6)(7)(8)(9). Recent studies showed that Cr also has antioxidant, anti-inflammatory and immunomodulatory effects (10), potentially promoting vascular protection (2). ...
... The daily creatinine excretion in urine is directly proportional to the total body creatine, and in particular to muscle mass (i.e. 20-25 mg/kg/24h in children and adults, and lower in infants younger than 2 years) (3,11). ...
Article
Full-text available
Creatine has become the most popular dietary supplement in sport and exercise physiology. In humans creatine is synthesized by the kidneys, pancreas and liver and transported mainly into brain, skeletal and cardiac muscle. Phosphocreatine is a high-energy content molecule, essential for the ADP to ATP conversion during intensive physical activity. Creatine and phosphocreatine are crucial in the energy shuttle system of high-energy phosphates between the mitochondrial ATP production and the cytosolic ATP consumption. Creatine supplementation increases lean body mass acting on myogenic regulatory factors. During muscular recovery, creatine supplementation regulates the regeneration process by reduction of muscle damage-induced inflammation and oxidative stress, activation and proliferation of satellite cells and regulation of calcium transport in muscle. The effects of creatine supplementation on muscle physiology are beneficial in anaerobic/aerobic exercises. In several muscle disorders (muscular dystrophies, in idiopathic inflammatory myopathies) creatine improved functional performance, but apparently not in metabolic myopathies; in McArdle diseases it may even have paradoxical effects. More research is warranted to better understand the short and long-term effects and safety of creatine supplementation among adolescents or elderly, as well as in different types of muscle diseases; for the two enzymatic genetic defects of creatine biosynthesis – arginine: glycine amidinotransferase (AGAT) and guanidinoacetate methyltransferase (GAMT), respectively – normal neurodevelopment has been achieved in early initiation of creatine therapy.
... However, we suggest that creatine-based MIPS positively affected performance fatigability (CV slopes) and TtT after REP, while no effects were observed on central factors (FD slopes). Even though MIPS was unable to significantly affect maximal force production (MVC) or performance outcomes (WRPM or BCRs), the positive effect on CV slopes and TtT registered in MIPS, but not in CC and PLA, may relate to the acute positive action of the supplement on peripheral components of performance fatigability, independently from the protons buffering function of creatine (38) and its ergogenic contribution (34). The observed results after MIPS may be linked to two possible additional mechanisms, which involve other components of the mixture, able to synergistically produce benefits to different levels of muscle work intensities, as we observed through the measure of CV slopes at 20 and 60% of MVC: (1) an acute role of β-alanine on the buffer capacity of the muscle during the fatiguing task as previously hypothesized by Invernizzi et al. (7), although we were not able to provide biochemical evidence of this assertion by measuring differences of blood pH, and (2) an overall "antifatigue" effect due to the presence of molecules able to regulate recognized mechanisms involved in the onset of high-intensity resistance exercise-induced fatigue (39)(40)(41), such as glutamine, arginine, and taurine. ...
Article
Full-text available
Background This study aims to investigate the acute effects of a single oral administration of a creatine-based multi-ingredient pre-workout supplement (MIPS) on performance fatigability and maximal force production after a resistance exercise protocol (REP). Methods Eighteen adult males (age: 23 ± 1 years; body mass: 76.4 ± 1.5 kg; height: 1.77 ± 0.01 m) were enrolled in a randomized, double-blind, crossover design study. Subjects received a single dose of a MIPS (3 g of creatine, 2 g of arginine, 1 g of glutamine, 1 g of taurine, and 800 mg of β-alanine) or creatine citrate (CC) (3 g of creatine) or a placebo (PLA) in three successive trials 1 week apart. In a randomized order, participants consumed either MIPS, CC, or PLA and performed a REP 2 h later. Before ingestion and immediately after REP, subjects performed isometric contractions of the dominant biceps brachii: two maximal voluntary contractions (MVCs), followed by a 20% MVC for 90 s and a 60% MVC until exhaustion. Surface electromyographic indices of performance fatigability, conduction velocity (CV), and fractal dimension (FD) were obtained from the surface electromyographic signal (sEMG). Time to perform the task (TtT), basal blood lactate (BL), and BL after REP were also measured. Results Following REP, statistically significant (P < 0.05) pre–post mean for ΔTtT between MIPS (−7.06 s) and PLA (+0.222 s), ΔCV slopes (20% MVC) between MIPS (0.0082%) and PLA (−0.0519%) and for ΔCV slopes (60% MVC) between MIPS (0.199%) and PLA (−0.154%) were found. A pairwise comparison analysis showed no statistically significant differences in other variables between groups and condition vs. condition. Conclusion After REP, a creatine-enriched MIPS resulted in greater improvement of sEMG descriptors of performance fatigability and TtT compared with PLA. Conversely, no statistically significant differences in outcomes measured were observed between CC and PLA or MIPS and CC.
... The methods for animals to obtain Cr can be categorized as endogenous and exogenous. The endogenous method mainly generates GAA through arginine and glycine, and then synthesizes Cr with methionine in the liver, but this does not meet the animals' needs (79). Exogenous Cr sources mainly include animal protein raw materials (meat and bone meal) and fish protein raw materials (fish meal) (80), while plant raw materials lack Cr or its precursor. ...
Article
Full-text available
Guanidinoacetic acid is the direct precursor of creatine and its phosphorylated derivative phosphocreatine in the body. It is a safe nutritional supplement that can be used to promote muscle growth and development. Improving the growth performance of livestock and poultry and meat quality is the eternal goal of the animal husbandry, and it is also the common demand of today's society and consumers. A large number of experimental studies have shown that guanidinoacetic acid could improve the growth performance of animals, promote muscle development and improve the health of animals. However, the mechanism of how it affects muscle development needs to be further elucidated. This article discusses the physical and chemical properties of guanidinoacetic acid and its synthesis pathway, explores its mechanism of how it promotes muscle development and growth, and also classifies and summarizes the impact of its application in animal husbandry, providing a scientific basis for this application. In addition, this article also proposes future directions for the development of this substance.
... Creatine is one of the most popular nutritional ergogenic aids for athletes (Kreider et al., 2017). Studies have consistently shown that creatine supplementation can improve exercise performance, through an increase of intramuscular PC concentration, and may enhance training adaptation/muscle hypertrophy by controlling molecular pathways (e.g., and myogenin) involved in muscle protein expression (Negro et al., 2019). Furthermore, creatine supplementation might influence postexercise muscle recovery by enhancing muscle satellite cell proliferation (Vierck et al., 2003;Olsen et al., 2006). ...
Article
Full-text available
Carnitine palmitoyltransferase II (CPTII) deficiency is the most frequent inherited disorder regarding muscle fatty acid metabolism, resulting in a reduced mitochondrial long-chain fatty acid oxidation during endurance exercise. This condition leads to a clinical syndrome characterized by muscle fatigue and/or muscle pain with a variable annual frequency of severe rhabdomyolytic episodes. While since the CPTII deficiency discovery remarkable scientific advancements have been reached in genetic analysis, pathophysiology and diagnoses, the same cannot be said for the methods of treatments. The current recommendations remain those of following a carbohydrates-rich diet with a limited fats intake and reducing, even excluding, physical activity, without, however, taking into account the long-term consequences of this approach. Suggestions to use carnitine and medium chain triglycerides remain controversial; conversely, other potential dietary supplements able to sustain muscle metabolism and recovery from exercise have never been taken into consideration. The aim of this review is to clarify biochemical mechanisms related to nutrition and physiological aspects of muscle metabolism related to exercise in order to propose new theoretical bases of treatment which, if properly tested and validated by future trials, could be applied to improve the quality of life of these patients.
... It has been reported that this metabolite at the physiological level is associated with muscle hypertrophy and regulation of muscle repair upon damage. It carries out its effect by regulating mechanisms such as gene expression and inflammation in muscle [37]. Creatine is synthetized by an onset of three amino acids methionine, glycine, and arginine, and therefore, a decrease in the level of creatine can be accompanied by a reduction of essential amino acids, similar to that observed in our data for proline and tryptophan ( Fig. 5c and Table 3). ...
Article
Full-text available
Inflammatory bowel disease is a multifactorial etiology, associated with environmental factors that can trigger both debut and relapses. A high level of tumor necrosis factor-α in the gut is the main consequence of immune system imbalance. The aim of treatment is to restore gut homeostasis. In this study, fresh blood and serum samples were used to identify biomarkers and to discriminate between Crohn’s disease and ulcerative colitis patients under remission treated with anti-TNF. Metabolomics based on Nuclear Magnetic Resonance spectroscopy (NMR) was used to detect unique biomarkers for each class of patients. Blood T lymphocyte repertories were characterized, as well as cytokine and transcription factor profiling, to complement the metabolomics data. Higher levels of homoserine-methionine and isobutyrate were identified as biomarkers of Crohn’s disease with ileocolic localization. For ulcerative colitis, lower levels of creatine-creatinine, proline, and tryptophan were found that reflect a deficit in the absorption of essential amino acids in the gut. T lymphocyte phenotyping and its functional profiling revealed that the overall inflammation was lower in Crohn’s disease patients than in those with ulcerative colitis. These results demonstrated that NMR metabolomics could be introduced as a high-throughput evaluation method in routine clinical practice to stratify both types of patients related to their pathology. Key messages NMR metabolomics is a non-invasive tool that could be implemented in the normal clinical practice for IBD to assess beneficial effect of the treatment. NMR metabolomics is a useful tool for precision medicine, in order to sew a specific treatment to a specific group of patients. Finding predictors of response to IFX would be desirable to select patients affected by IBD. Immunological status of inflammations correlates with NMR metabolomics biomarkers.
... Afterwards, increasing creatine stores in the muscles can be maintained by the daily intake of 2 to 5 grams of creatine supplementation (maintenance phase). However, the variability of the increase in muscle creatine in people is very variable and can range from 0 to 40% [27]. Creatine has several forms and one of its types is creatine ethyl ester (CEE). ...
Article
Full-text available
Study aim: The aim of this study to determine whether creatine ethyl ester (CEE) supplementation combined with resistance training (RT) is effective for improving hormonal changes, body composition and muscle strength in underweight non-athlete men. Materials and methods: Sixteen underweight non-athlete men participated in this double-blind study and were randomly assigned to one of two groups: RT with placebo (RT + PL, n = 8) and RT with CEE supplementation (RT + CEE, n = 8). The participants performed 6 weeks of RT (60–80% 1RM) combined with CEE or PL. 48 hours before and after the training period, muscle strength (1RM for leg press and bench press), body composition (percentage of body fat, circumference measurements of the arm and thigh), serum levels of testosterone, cortisol, and growth hormone (GH) of the participant were measurements. Results: Significant increases were observed for weight, muscle strength and muscle mass, serum levels of testosterone and GH between pre and post-test in the RT + CEE group (p < 0.05). In addition, cortisol level was significantly decreased in the post-test in the RT+CEE group. The decrease in fat percent was greater in the RT + PL group than in the RT + CEE group (%change = –6.78 vs. –0.76, respectively). Weight and leg strength changes in the RT + CEE group were significant compared to the RT + PL group (p < 0.001, p = 0.05, p = 0.001; respectively). However, in other variables, despite the increase of GH and testosterone levels and lower levels of cortisol in the RT + CEE group, no significant differences were observed between the two groups (p < 0.05). Conclusion: It seems that the consumption of CEE combined with RT can have significant effects on body weight and leg strength in underweight non-athlete men. This supplement may provide a potential nutritional intervention to promote body weight in underweight men.
Article
Full-text available
Background The intestine of young ruminants is in the developmental stage and has weaker resistance to the changes of external environment. Improving intestinal health is vital to promoting growth of young ruminants. This study investigated effects of guanidino acetic acid (GAA) and rumen‐protected betaine (RPB) supplementation on growth, dietary nutrient digestion and GAA metabolism in the small intestine of sheep. Methods Eighteen healthy Kazakh rams (27.46 ± 0.10 kg of body weight and 3‐month old) were categorized into control, test group I and test group II, which were fed a basal diet, 1500 mg/kg GAA and 1500 mg/kg GAA + 600 mg/kg RPB, respectively. Results Compared with control group, test group II had increased (p < 0.05) average daily gain, plasma creatine level, ether extract (EE) and phosphorus digestibility on day 30. On day 60, the EE apparent digestibility, jugular venous plasma GAA, GAA content in the duodenal mucosa and GAA content in the jejunal and ileal mucosa of test group II were higher (p < 0.05) than other groups. Transcriptome analysis revealed that the differentially expressed genes (DEGs) involved in the duodenal pathways of oxidative phosphorylation and non‐alcoholic fatty liver disease were significantly altered in test group II versus test group I (p < 0.05). Moreover, in the jejunum, the MAPK signalling pathway, complement and coagulation cascade and B‐cell receptor signalling pathway were significantly enriched, with ATPase, solute carrier transporter protein, DHFR, SI, GCK, ACACA and FASN being the significantly DEGs (p < 0.05). Conclusion Dietary supplementation of RPB on top of GAA in sheep diets may promote sheep growth and development by improving the body's energy, amino acid, glucose and lipid metabolism capacity.
Chapter
Full-text available
A constant supply of adenosine triphosphate (ATP) is essential for function in all cells and especially so in skeletal muscle cells to power the contractions needed to enable the many forms of movement required in our daily lives and for exercise and sporting events. The muscle stores of ATP are small, and metabolic pathways must maintain the required rates of ATP resynthesis when the demand for ATP is high. Oxidative (“aerobic”) phosphorylation uses reducing equivalents from the metabolism of carbohydrate and fat to produce ATP and is the default energy system in skeletal muscle. Substrate-level phosphorylation or “anaerobic metabolism” also plays a very important role in supplementing or buffering ATP production when aerobic ATP production cannot meet the needs of an activity. These situations include the transitions from rest to exercise and from one power output to a higher one, exercise that demands ATP provision rates above what can be provided aerobically, and in situations of suboptimal oxygen supply. Anaerobic energy is provided from phosphocreatine and muscle glycogen breakdown (anaerobic glycolysis). These systems can provide energy very quickly and at very high rates but are limited to short periods of time during high intensity exercise due to substrate depletion and increasing muscle acidosis. In most exercise and sporting situations, energy provision is maintained by contributions from both the aerobic and anaerobic sources to ensure that ATP resynthesis closely matches the exercise ATP demand.KeywordsAnaerobic metabolismSkeletal musclePhosphocreatineAnaerobic glycolysisGlycogenCarbohydrateLactateATP provisionAcidosisHigh-intensity exercise
Article
Full-text available
Creatine monohydrate (CrM) is one of the most widely used nutritional supplements among active individuals and athletes to improve high-intensity exercise performance and training adaptations. However, research suggests that CrM supplementation may also serve as a therapeutic tool in the management of some chronic and traumatic diseases. Creatine supplementation has been reported to improve high-energy phosphate availability as well as have antioxidative, neuroprotective, anti-lactatic, and calcium-homoeostatic effects. These characteristics may have a direct impact on mitochondrion’s survival and health particularly during stressful conditions such as ischemia and injury. This narrative review discusses current scientific evidence for use or supplemental CrM as a therapeutic agent during conditions associated with mitochondrial dysfunction. Based on this analysis, it appears that CrM supplementation may have a role in improving cellular bioenergetics in several mitochondrial dysfunction-related diseases, ischemic conditions, and injury pathology and thereby could provide therapeutic benefit in the management of these conditions. However, larger clinical trials are needed to explore these potential therapeutic applications before definitive conclusions can be drawn.
Article
Creatine improves flesh quality on mammalian but studies on crustaceans are scarce. In the present study, diets with six levels of creatine (1.23, 2.58, 5.12, 8.28, 14.12, 24.49 g kg⁻¹ diet) were hand-fed to juvenile Litopenaeus vannamei (IBW: 1.50 ± 0.02 g) reared in freshwater for 46 days. Results showed creatine supplementation did not affect the growth performance (FBW: 17.04 ± 1.28 g) or the content of guanidinoacetic acid in muscle and hepatopancreas whereas significantly increased muscular creatine content. Diet with 8.28 g kg⁻¹ creatine significantly increased muscular hardness and chewiness by decreasing myofiber diameter and increasing myofiber density. Additionally, creatine downregulated the mRNA expression of fast sMyHC1, sMyHC2, sMyHC6a and upregulated slow sMyHC5 and sMyHC15 mRNA expression. Muscular protein, collagen, total amino acid and flavor amino acid contents increased with creatine supplementation. In conclusion, the diet with 8.28 g kg⁻¹ creatine improved the flesh quality of L.vannamei.
Article
Full-text available
Creatine (Cr) is produced endogenously in the liver or obtained exogenously from foods, such as meat and fish. In the human body, 95 % of Cr is located in the cytoplasm of skeletal muscle either in a phosphorylated (PCr) or free form (Cr). PCr is essential for the immediate rephosphorylation of adenosine diphosphate to adenosine triphosphate. PCr is rapidly degraded at the onset of maximal exercise at a rate that results in muscle PCr reservoirs being substantially depleted. A well-established strategy followed to increase muscle total Cr content is to increase exogenous intake by supplementation with chemically pure synthetic Cr. Most Cr supplementation regimens typically follow a well-established loading protocol of 20 g day(-1) of Cr for approximately 5-7 days, followed by a maintenance dose at between 2 and 5 g day(-1) for the duration of interest, although more recent studies tend to utilize a 0.3-g kg(-1) day(-1) supplementation regimen. Some studies have also investigated long-term supplementation of up to 1 year. Uptake of Cr is enhanced when taken together with carbohydrate and protein and/or while undertaking exercise. Cr supplementation has been shown to augment muscle total Cr content and enhance anaerobic performance; however, there is also some evidence of indirect benefits to aerobic endurance exercise through enhanced thermoregulation. While there is an abundance of data supporting the ergogenic effects of Cr supplementation in a variety of different applications, some individuals do not respond, the efficacy of which is dependent on a number of factors, such as dose, age, muscle fiber type, and diet, although further work in this field is warranted. Cr is increasingly being used in the management of some clinical conditions to enhance muscle mass and strength. The application of Cr in studies of health and disease has widened recently with encouraging results in studies involving sleep deprivation and cognitive performance.
Article
Full-text available
A formula has been developed to predict creatinine clearance (Ccr) from serum creatinine (Scr) in adult males: (see article)(15% less in females). Derivation included the relationship found between age and 24-hour creatinine excretion/kg in 249 patients aged 18-92. Values for Ccr were predicted by this formula and four other methods and the results compared with the means of two 24-hour Ccr's measured in 236 patients. The above formula gave a correlation coefficient between predicted and mean measured Ccr's of 0.83; on average, the difference predicted and mean measured values was no greater than that between paired clearances. Factors for age and body weight must be included for reasonable prediction.
Article
Full-text available
Objective. Rheumatoid cachexia (muscle wasting) in rheumatoid arthritis (RA) patients contributes to substantial reductions in strength and impaired physical function. The objective of this randomised control trial was to investigate the effectiveness of oral creatine (Cr) supplementation in increasing lean mass and improving strength and physical function in RA patients. Method. In a double-blind design, 40 RA patients, were randomised to either 12 weeks supplementation of Cr or placebo. Body composition (dual energy x-ray absorptiometry, DXA, and bioelectrical impedance spectroscopy, BIS), strength and objectively-assessed physical function were measured at: baseline, day 6, week 12 and week 24. Data analysis was performed by ANCOVA. Results. Creatine supplementation increased appendicular lean mass (ALM; a surrogate measure of muscle mass) by 0.52 (± 0.13) kg (P = 0.004 versus placebo), and total LM by 0.60 (± 0.37) kg (P = 0.158). The change in LM concurred with the gain in intracellular water (0.64 ± 0.22 L, P = 0.035) measured by BIS. Despite increasing ALM, Cr supplementation, relative to placebo, failed to improve isometric knee extensor (P = 0.408), handgrip strength (P = 0.833), or objectively-assessed physical function (P's = 0.335 – 0.764). Conclusion. In patients with RA, creatine supplementation increased muscle mass, but not strength or objective physical function. No treatment-related adverse effects were reported suggesting that Cr supplementation may offer a safe and acceptable adjunct treatment for attenuating muscle loss; this treatment may be beneficial for patients suffering from severe rheumatoid cachexia.
Article
Full-text available
This study investigated the effects of creatine and sodium bicarbonate coingestion on mechanical power during repeated sprints. Nine well-trained men (age = 21.6 ± 0.9 yr, stature = 1.82 ± 0.05 m, body mass = 80.1 ± 12.8 kg) participated in a double-blind, placebo-controlled, counterbalanced, crossover study using six 10-s repeated Wingate tests. Participants ingested either a placebo (0.5 g·kg-1 of maltodextrin), 20 g·d-1 of creatine monohydrate + placebo, 0.3 g·kg-1 of sodium bicarbonate + placebo, or coingestion + placebo for 7 days, with a 7-day washout between conditions. Participants were randomized into two groups with a differential counterbalanced order. Creatine conditions were ordered first and last. Indices of mechanical power output (W), total work (J) and fatigue index (W·s-1) were measured during each test and analyzed using the magnitude of differences between groups in relation to the smallest worthwhile change in performance. Compared with placebo, both creatine (effect size (ES) = 0.37–0.83) and sodium bicarbonate (ES = 0.22–0.46) reported meaningful improvements on indices of mechanical power output. Coingestion provided small meaningful improvements on indices of mechanical power output (W) compared with sodium bicarbonate (ES = 0.28–0.41), but not when compared with creatine (ES = -0.21–0.14). Coingestion provided a small meaningful improvement in total work (J; ES = 0.24) compared with creatine. Fatigue index (W·s-1) was impaired in all conditions compared with placebo. In conclusion, there was no meaningful additive effect of creatine and sodium bicarbonate coingestion on mechanical power during repeated sprints.
Article
Full-text available
Creatine supplementation in close proximity to resistance training may be an important strategy for increasing muscle mass and strength; however, it is unknown whether creatine supplementation before or after resistance training is more effective for aging adults. Using a double-blind, repeated measures design, older adults (50–71 years) were randomized to 1 of 3 groups: creatine before (CR-B: n = 15; creatine (0.1 g/kg) immediately before resistance training and placebo (0.1 g/kg cornstarch maltodextrin) immediately after resistance training), creatine after (CR-A: n = 12; placebo immediately before resistance training and creatine immediately after resistance training), or placebo (PLA: n = 12; placebo immediately before and immediately after resistance training) for 32 weeks. Prior to and following the study, body composition (lean tissue, fat mass; dual-energy X-ray absorptiometry) and muscle strength (1-repetition maximum leg press and chest press) were assessed. There was an increase over time for lean tissue mass and muscle strength and a decrease in fat mass (p < 0.05). CR-A resulted in greater improvements in lean tissue mass (Δ 3.0 ± 1.9 kg) compared with PLA (Δ 0.5 ± 2.1 kg; p < 0.025). Creatine supplementation, independent of the timing of ingestion, increased muscle strength more than placebo (leg press: CR-B, Δ 36.6 ± 26.6 kg; CR-A, Δ 40.8 ± 38.4 kg; PLA, Δ 5.6 ± 35.1 kg; chest press: CR-B, Δ 15.2 ± 13.0 kg; CR-A, Δ 15.7 ± 12.5 kg; PLA, Δ 1.9 ± 14.7 kg; p < 0.025). Compared with resistance training alone, creatine supplementation improves muscle strength, with greater gains in lean tissue mass resulting from post-exercise creatine supplementation.
Article
Creatine is a popular ergogenic supplement in sports nutrition. Yet, supplementation of creatine occasionally caused adverse effects such as gastrointestinal complaints, muscle cramps and an increase in body weight. Creatine monohydrate has already been evaluated by different competent authorities and several have come to the conclusion that a daily intake of 3 g creatine per person is unlikely to pose safety concerns, focusing on healthy adults with exclusion of pregnant and breastfeeding women. Possible vulnerable subgroups were also discussed in relation to the safety of creatine. The present review provides an up‐to‐date overview of the relevant information with special focus on human studies regarding the safety of creatine monohydrate and other marketed creatine forms, in particular creatine pyruvate, creatine citrate, creatine malate, creatine taurinate, creatine phosphate, creatine orotate, creatine ethyl ester, creatine pyroglutamate, creatine gluconate, and magnesium creatine chelate. Limited data are available with regard to the safety of the latter creatine forms. Considering an acceptable creatine intake of 3 g per day, most of the evaluated creatine forms are unlikely to pose safety concerns, however some safety concerns regarding a supplementary intake of creatine orotate, creatine phosphate, and magnesium creatine chelate are discussed here.
Chapter
Endurance athletes often seek nutritional strategies inclusive of dietary supplements to maximize their performance. Effective supplement routines, however, are only beneficial when built on a sound training diet, training regimen, and an appreciation of dietary needs relative to their training schema. While traditional dietary interventions are based on the glycemic index of carbohydrate, coupled with the addition of protein quality and quantity, recent innovations have introduced the potential utility of long chain glucose polymers and dietary nitrates, such as beetroot juice. Consideration is also given to the utility of supplement strategies aimed at attenuating immune responses accompanying training and competition. A key to implementing successful supplementation routines is the appreciation that athletes should be considered on an individual basis and training volume and intensity must be taken into account.
Article
Creatine is widely used by both elite and recreational athletes as an ergogenic aid to enhance anaerobic exercise performance. Older individuals also use creatine to prevent sarcopenia and, accordingly, may have therapeutic benefits for muscle wasting diseases. Although the effect of creatine on the musculoskeletal system has been extensively studied, less attention has been paid to its potential effects on other physiological systems. Because there is a significant pool of creatine in the brain, the utility of creatine supplementation has been examined in vitro as well as in vivo in both animal models of neurological disorders and in humans. While the data are preliminary, there is evidence to suggest that individuals with certain neurological conditions may benefit from exogenous creatine supplementation if treatment protocols can be optimized. A small number of studies that have examined the impact of creatine on the immune system have shown an alteration in soluble mediator production and the expression of molecules involved in recognizing infections, specifically toll-like receptors. Future investigations evaluating the total impact of creatine supplementation are required to better understand the benefits and risks of creatine use, particularly since there is increasing evidence that creatine may have a regulatory impact on the immune system.
Article
Age-related sarcopenia, composed of myopenia (a decline in muscle mass) and dynapenia (a decline in muscle strength), can compromise physical function, increase risk of disability, and lower quality of life in older adults. There are no available pharmaceutical treatments for this condition, but evidence shows resistance training (RT) is a viable and relatively low-cost treatment with an exceptionally positive side effect profile. Further evidence suggests that RT-induced increases in muscle mass, strength, and function can be enhanced by certain foods, nutrients, or nutritional supplements. This brief review focuses on adjunctive nutritional strategies, which have a reasonable evidence base, to enhance RT-induced gains in outcomes relevant to sarcopenia and to reducing risk of functional declines. © 2015 American Society for Nutrition.
Article
Purpose: Our primary purpose was to determine the effect of 12 months of creatine (Cr) supplementation during a supervised resistance training program on properties of bone in postmenopausal women. Methods: Participants were randomized (double-blind) into two groups: resistance training (3 d·wk) and Cr supplementation (0.1 g·kg·d) or resistance training and placebo (Pl). Our primary outcome measures were lumbar spine and femoral neck bone mineral density (BMD). Secondary outcome measures were total hip and whole-body BMD, bone geometric properties at the hip, speed of sound at the distal radius and tibia, whole-body lean tissue mass, muscle thickness, and bench press and hack squat strength. Forty-seven women (57 (SD, 6) yr; Cr, n = 23; Pl, n = 24) were randomized, with 33 analyzed after 12 months (Cr, n = 15; Pl, n = 18). Results: Cr attenuated the rate of femoral neck BMD loss (-1.2%; absolute change (95% confidence interval), -0.01 (-0.025 to 0.005) g·cm) compared with Pl (-3.9%; -0.03 (-0.044 to -0.017) g·cm; P < 0.05) and also increased femoral shaft subperiosteal width, a predictor of bone bending strength (Cr, 0.04 (-0.09 to 0.16) cm); Pl, -0.12 (-0.23 to -0.01) cm; P < 0.05). Cr increased relative bench press strength more than Pl (64% vs 34%; P < 0.05). There were no differences between groups for other outcome measures. There were no differences between groups for reports of serum liver enzyme abnormalities, and creatinine clearance was normal for Cr participants throughout the intervention. Conclusions: Twelve months of Cr supplementation during a resistance training program preserves femoral neck BMD and increases femoral shaft superiosteal width, a predictor of bone bending strength, in postmenopausal women.